Impairments in Executive Functioning in Patients with Comorbid Substance Use and Personality Disorders: A Systematic Review
| dc.contributor.author | Moraleda Barreno, Enrique | |
| dc.contributor.author | Cáceres Pachón, María Pilar | |
| dc.contributor.author | Lozano Rojas, Óscar Martín | |
| dc.contributor.author | Pérez Moreno, Pedro Juan | |
| dc.contributor.author | Lorca Marín, José Andrés | |
| dc.contributor.author | Fernández Calderón, Fermín | |
| dc.contributor.author | Díaz Batanero, María Carmen | |
| dc.contributor.author | Gómez Bujedo, Jesús | |
| dc.date.accessioned | 2025-01-14T10:55:33Z | |
| dc.date.available | 2025-01-14T10:55:33Z | |
| dc.date.issued | 2020-10-22 | |
| dc.description.abstract | Objective: The purpose of this systematic review was to examine the evidence for impaired executive functioning in patients diagnosed with a dual pathology of personality disorder (PD) and substance use disorder, and to identify whether differences exist in comparison to those with a single diagnosis. Methods: A systematic search was conducted to identify studies using measures of executive functioning in patients with PD-substance use disorder dual pathology. Sixteen studies were selected. Results: The results indicate that dual pathology patients with Cluster C personality disorder do not differ from controls, and that the presence of dual pathology does not influence the updating domain of executive functioning. The findings were inconclusive with regard to dual pathology patients with Cluster B personality disorders. Whilst the various studies consistently show that these patients show worse performance than the control groups, here are contradictory results with regard to whether Cluster B personality disorders add more alterations in executive functioning to those that already appear in substance use disorder. Conclusions: The results suggest the need for further research that more adequately controls variables such as time in treatment, medication, and sample size, whilst there is also a need to employ longitudinal designs that include more patients from Clusters A and C. | es_ES |
| dc.description.department | Psicología Clínica y Experimental | es_ES |
| dc.description.sponsorship | National Drug Strategy, “Ministry of Health, Social Services and Equality” (Spain) under Grant “Q7150008F-2016/034.” | es_ES |
| dc.identifier.citation | Moraleda-Barreno, E., Cáceres Pachón, M. del P., Lozano, Ó. M., Pérez Moreno, P. J., Lorca Marín, J. A., Fernández-Calderón, F., Díaz Batanero, C., & Gómez-Bujedo, J. (2020). Impairments in Executive Functioning in Patients with Comorbid Substance Use and Personality Disorders: A Systematic Review. In Journal of Dual Diagnosis (Vol. 17, Issue 1, pp. 64–79). Informa UK Limited. https://doi.org/10.1080/15504263.2020.1829769 | es_ES |
| dc.identifier.doi | 10.1080/15504263.2020.1829769 | |
| dc.identifier.issn | 1550-4263 | |
| dc.identifier.issn | 1550-4271 (electrónico) | |
| dc.identifier.uri | https://hdl.handle.net/10272/24811 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | Taylor and Francis Group | es_ES |
| dc.relation.projectID | Q7150008F-2016/034/Delegación del Gobierno para el Plan Nacional sobre Drogas/Longitudinal study about the efect of treatment on executive function recovery in patients with cocaine and alcohol dependence: implications on treatment outcomes” f | es_ES |
| dc.relation.publisherversion | https://doi.org/10.1080/15504263.2020.1829769 | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.subject.other | Dual pathology | es_ES |
| dc.subject.other | Substance use disorder | es_ES |
| dc.subject.other | Personality disorder | es_ES |
| dc.subject.other | Executive function | es_ES |
| dc.subject.other | Systematic review | es_ES |
| dc.subject.unesco | 3201.05 Psicología Clínica | es_ES |
| dc.subject.unesco | 2490 Neurociencias | es_ES |
| dc.title | Impairments in Executive Functioning in Patients with Comorbid Substance Use and Personality Disorders: A Systematic Review | es_ES |
| dc.type | journal article | es_ES |
| dc.type.hasVersion | AM | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | d07454ad-3723-44b2-baa2-7d7227f5763f | |
| relation.isAuthorOfPublication | 1ef8c5af-b9cb-4093-a001-7ad6fb8cc276 | |
| relation.isAuthorOfPublication | fc58598b-48ec-4404-819c-f3123bc4fd72 | |
| relation.isAuthorOfPublication | 569427cb-9386-4bfe-aa10-edc6e0f2ffd1 | |
| relation.isAuthorOfPublication | 2af5f3a8-6de2-4e7f-a8c2-5d2be82fbc5c | |
| relation.isAuthorOfPublication | 143af3ce-98c3-4efd-8384-4eb066802273 | |
| relation.isAuthorOfPublication | 08d54c72-3742-442e-bccb-827f49d18ade | |
| relation.isAuthorOfPublication.latestForDiscovery | d07454ad-3723-44b2-baa2-7d7227f5763f |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 2021 - Postprint - Impairments in executive functioning in patients with comorbid substance use and personality disorders- a systematic review.pdf
- Size:
- 752.28 KB
- Format:
- Adobe Portable Document Format
- Description:
- Versión postprint


